EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Widespread SARS-CoV-2 exposure in West Africa: findings from a 20,748-participant multi-country seroepidemiology study

Aniefiok John Udoakang, Daniel Oduro-Mensah, Gloria Amegatcher, Onikepe Folarin, Isah Abubakar Aliyu, Irene Amoakoh Owusu, Francis Dzabeng, Alphonse Ouedraogo, Reuben Ayivor-Djanie, Jones Gyamfi, Moumouni Armel Sanou, Kesego Tapela und 48 weitere

Frontiers in Public Health · 2026

DOI: 10.3389/fpubh.2026.1945355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, 2026. Verfasst von Aniefiok John Udoakang und 59 weiteren Autor:innen. Beteiligte Einrichtung: West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Accra, Ghana. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Africa seemed to have had low SARS-CoV-2 infection and COVID-19 morbidity and mortality. While several studies reported high SARS-CoV-2 seropositivity among healthy Africans, others hypothesized that this could have resulted from pre-existing cross-reactive antibodies. Our study tracks trends in seropositivity across three West African countries during the Delta- and Omicron-dominant pandemic periods using validated SARS-CoV-2 IgG/IgM rapid diagnostic tests (Prestige Diagnostics in Ghana and Burkina Faso; SD Biosensor in Nigeria).

Methods

Cross-sectional studies were conducted in three West African countries (Burkina Faso, Ghana, and Nigeria), with study sites conveniently selected within each country. Using validated immunoassay kits with published validation procedures, SARS-CoV-2 antibodies were detected in peripheral blood during the Delta- and Omicron-dominant periods. Because we did not perform widespread viral sequencing on participant samples, we could not attribute seropositivity to a specific variant; instead, we classified sampling periods by the variant reported as dominant nationally/globally at the time of sample collection. Participants’ demographic and clinical data were obtained using a semi-structured questionnaire, and the primary outcome was the proportion of each population with SARS-CoV-2 antibodies.

Results

Across the 3 countries, 20,748 participants were recruited, and SARS-CoV-2 IgG seropositivity ranged from 24.1 to 76.4%, with higher rates during the Omicron-dominant period. All sites showed low self-reported vaccination rates, suggesting that seropositivity may be primarily driven by natural infection rather than vaccination. While there was a significant positive association between seropositivity and age across all sites, the association with other demographic factors was country-dependent, and most participants expressed positive opinions of vaccination.

Conclusion

This is one of the largest multi-country community-based SARS-CoV-2 seroepidemiology studies in Africa, showing widespread exposure to SARS-CoV-2 infection among our study population across three West African countries. These findings are consistent with a marked disconnect between high population exposure and low reported clinical burden, underscoring the need for strengthened community surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2HumansSeroepidemiologic StudiesFemaleAdultMaleCross-Sectional StudiesMiddle AgedAdolescentYoung AdultBurkina FasoAntibodies, ViralGhanaNigeriaChildAgedImmunoglobulin GWest African People

Stichwörter der Autor:innen

Burkina FasoCOVID-19GhanaNigeriaSARS-CoV-2West Africaseroepidemiologyseroprevalence

Substanzen

Antibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
  • Department of Biosciences and Biotechnology, University of Medical Sciences, Ondo, Nigeria.
  • Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana.
  • Department of Medical Laboratory Sciences, School of Basic and Allied Health Sciences, University of Ghana, Korle Bu, Ghana.
  • African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), Redeemer's University, Ede, Nigeria.
  • Africa Center of Excellence for Population Health and Policy (ACEPHAP), Bayero University, Kano, Nigeria.

Zitieren

APA

Udoakang, A. J., Oduro-Mensah, D., Amegatcher, G., Folarin, O., Aliyu, I. A., Owusu, I. A., Dzabeng, F., Ouedraogo, A., Ayivor-Djanie, R., Gyamfi, J., Sanou, M. A., Tapela, K., Binyet, M., Boateng, K. A., Amole, T. G., Okolie, J., Musa, B. M., Bala, J. A., Akano, K., …, & Amponsah, G. (2026). Widespread SARS-CoV-2 exposure in West Africa: findings from a 20,748-participant multi-country seroepidemiology study. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2026.1945355

Vancouver

Udoakang AJ, Oduro-Mensah D, Amegatcher G, Folarin O, Aliyu IA, Owusu IA, et al. Widespread SARS-CoV-2 exposure in West Africa: findings from a 20,748-participant multi-country seroepidemiology study. Frontiers in Public Health. 2026. doi:10.3389/fpubh.2026.1945355

BibTeX
@article{Udoakang2026,
  author = {Udoakang, Aniefiok John and Oduro-Mensah, Daniel and Amegatcher, Gloria and Folarin, Onikepe and Aliyu, Isah Abubakar and Owusu, Irene Amoakoh and Dzabeng, Francis and Ouedraogo, Alphonse and Ayivor-Djanie, Reuben and Gyamfi, Jones and Sanou, Moumouni Armel and Tapela, Kesego and Binyet, Manfreddy and Boateng, Kyerewaa Akuamoah and Amole, Taiwo Gboluwaga and Okolie, Johnson and Musa, Baba Maiyaki and Bala, Jamilu Abubakar and Akano, Kazeem and Olayemi, Ajibade Olufunke and Achonduh-Atijegbe, Olivia and Nnennaya, Ajayi and Ihere, Okoro Sylvanus and Benedict, Azuogu and Ukpabi, Okechukwu and Kingsley, Ojide Chiedozie and Abu, Augustine and Osoba, Moyosoore and Oyejide, Nicholas and Owusu, Evans Agyapong and Adade, Bismark and Sampah, James Ekow and Ishaq, Samed and Agyei, George and Benjamin, Boateng and Oduro-Obeng, William and Ogoe-Anderson, Janet and Amekpordi, Nicholas Aloba and Alhassan, Safiatu and Afrifa, David and Opoku, Bismark Akwasi and Ayodeji, Oladele Oluwafemi and Abejegah, Chukwuyem and Adedosu, Akinola Nelson and Ahmed, Liasu Adeagbo and Serme, Samuel S and Ouattara, Maurice and Hien, Denise and Issa, Nebié and Boateng, Rachael O and Opurum, Precious C and Oyawoye, Fatima O and Ayeke, Dzidzor Yawa and Ofori, Michael and Achille, Nikiema Sindimbasba and Sow, Bazoumana and Pare-Toe, Lea and Guissou, Charles and Minna, Bismark and Amponsah, Gifty},
  title = {Widespread SARS-CoV-2 exposure in West Africa: findings from a 20,748-participant multi-country seroepidemiology study},
  journal = {Frontiers in Public Health},
  year = {2026},
  doi = {10.3389/fpubh.2026.1945355}
}
Kostenlos starten →